Sung; Victoria

Patent Applications and Registrations

Patent applications and USPTO patent grants for Sung; Victoria.The latest application filed is for "cd47 antibodies and methods of use thereof".

Company Profile

5.7.14

Sung; Victoria - San Francisco CA
Sung; Victoria - Emeryville CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Cd47 Antibodies And Methods Of Use Thereof App 20210371522 - Sung; Victoria ; et al.	2021-12-02
Cd47 Antibodies And Methods Of Use Thereof App 20200255515 - Kind Code	2020-08-13
Vitro Cell Culture Methods For Beta-thalassemia Using Activin Type Ii Receptor Ligand Traps App 20200101157 - CAPPELLINI; Maria ; et al.	2020-04-02
In vitro cell culture methods for beta-thalassemia using activin type II receptor ligand traps Grant 10,548,976 - Cappellini , et al. Fe	2020-02-04
Activin-actrii Antagonists And Uses For Treating Bone And Other Disorders App 20190262423 - Sung; Victoria ; et al.	2019-08-29
Biomarker For Use In Treating Anemia App 20190049469 - Sung; Victoria ; et al.	2019-02-14
Activin-ActRII antagonists and uses for treating bone and other disorders Grant 10,195,249 - Sung , et al. Fe	2019-02-05
In Vitro Cell Culture Methods For Beta-thalassemia Using Activin Type Ii Receptor Ligand Traps App 20180161426 - CAPPELLINI; Maria ; et al.	2018-06-14
Activin-actrii Antagonists And Uses For Treating Bone And Other Disorders App 20150283209 - Sung; Victoria ; et al.	2015-10-08
Biomarker For Use In Treating Anemia App 20150276766 - Sung; Victoria ; et al.	2015-10-01
Methods For Treating Anemia App 20150266950 - Sung; Victoria ; et al.	2015-09-24
6-O-substituted benzoxazole and benzothiazole compounds and methods of inhibiting CSF-1R signaling Grant 8,710,048 - Sutton , et al. April 29, 2	2014-04-29
M-CSF-specific monoclonal antibody and uses thereof Grant 8,652,469 - Kavanaugh , et al. February 18, 2	2014-02-18
6-O-Substituted Benzoxazole and Benzothiazole Compounds and Methods of Inhibiting CSF-1R Signaling App 20120225861 - Sutton; James C. ; et al.	2012-09-06
6-O-substituted benzoxazole and benzothiazole compounds and methods of inhibiting CSF-1R signaling App 20100280006 - Sutton; James C. ; et al.	2010-11-04
M-CSF-Specific Monoclonal Antibody and Uses Thereof App 20100092464 - Kavanaugh; William M. ; et al.	2010-04-15
6-O-substituted benzoxazole and benzothiazole compounds and methods of inhibiting CSF-1R signaling Grant 7,553,854 - Sutton , et al. June 30, 2	2009-06-30
6-o-substituted Benzoxazole And Benzothiazole Compounds And Methods Of Inhibiting Csf-1r Signaling App 20080045528 - Sutton; JamesC ; et al.	2008-02-21
Methods of using ZC1 and ZC3 kinase substrate phosphorylation as biomarkers App 20050276757 - Wright, Jocelyn H. ; et al.	2005-12-15

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.